OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 164,800
+4,000 (2.49%)
Apr 10, 2026, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 3.35 trillion as of April 10, 2026. Its market cap has increased by 276.91% in one year.
Market Cap
3.35T
Enterprise Value
3.24T
Revenue
14.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
164,800.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 3.35T, an increase of 692.73%. That is a compound annual growth rate of 30.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.35T | 18.02% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 7.77T |
| HLB Co., Ltd. | 7.29T |
| Peptron | 6.62T |
| LigaChem Biosciences | 6.40T |
| Voronoi | 5.04T |
| SK bioscience | 3.27T |
| PharmaResearch | 3.06T |
| D&D Pharmatech | 3.04T |